Abogen has been invited to speak at the Vaccine and Therapeutic RNA Research Forum 2025, held on August 4–5 in Bangkok, Thailand.

Dr. Bo Ying, CEO of Abogen, will Join leading scientists,  including 2023 Nobel Laureate and mRNA pioneer Dr. Drew Weissman, to explore the future of RNA therapeutics. As a keynote speaker, he will share the company's latest advances in RNA research innovation.

Abogen's Speaking Sessions:

Keynote Talk 01

Topic: AI-driven mRNA and Ionized Lipid Development

Time: August 4, 2025 | 10:00–10:30 AM

Highlights: 

① Introduction to Abogen's xRNA (mRNA, circRNA, saRNA) platform architecture, demonstrating how AI technology is applied to optimize platform development and automated manufacturing processes;

② Update on the clinical progress of Abogen's current platform, including preliminary clinical safety data for the Varicella Zoster Virus (VZV) and Respiratory Syncytial Virus (RSV) vaccine programs, and the latest clinical efficacy and safety data for the ABO2203 program (mRNA-encoded CD3/CD19 T-cell engager);

③ Further outlook on the potential of Abogen's xRNA platform across diverse application scenarios.

Keynote Talk 02

Topic: Comparison and Potential Applications of mRNA, circular RNA and self-amplifying RNA Platform

Time: August 4, 2025 | 10:50 – 11:05 AM

Highlights: Introduction and comparison of Abogen's proprietary xRNA platform, covering three technological pathways: linear mRNA, circular RNA, and self-amplifying RNA. This session elaborates on their respective characteristics, advantages, and challenges, and explores their potential in various application scenarios.